title: Severe bilateral optic neuritis associated with prolonged linezolid therapy.
authors.forename: Frédéric
authors.initials: F
authors.lastname: Frippiat
authors.forename: Christelle
authors.initials: C
authors.lastname: Bergiers
authors.forename: Claire
authors.initials: C
authors.lastname: Michel
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Dujardin
authors.forename: Geneviève
authors.initials: G
authors.lastname: Derue
mesh_terms: D000081:Acetamides / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D005260:Female; D007839:Functional Laterality; D006801:Humans; D000069349:Linezolid; D009902:Optic Neuritis / Q000139:chemically induced*; D023303:Oxazolidinones / Q000009:adverse effects* / Q000627:therapeutic use; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology; D012293:Rifampin / Q000627:therapeutic use
chemical_list: D000081:Acetamides; D000890:Anti-Infective Agents; D000904:Antibiotics, Antitubercular; D023303:Oxazolidinones; D002939:Ciprofloxacin; D000069349:Linezolid; D012293:Rifampin